Ignite Creation Date:
2025-12-24 @ 10:10 PM
Ignite Modification Date:
2026-06-06 @ 8:17 AM
Study NCT ID:
NCT00779935
Status:
COMPLETED
Last Update Posted:
2017-05-11
First Post:
2008-10-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Growth Factor Concentration to Predict an Ankylosing Spondylitis Patient's Response to Infliximab (Study P04041)(COMPLETED)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Spondylitis, Ankylosing | View |
Keywords: